Results 151 to 160 of about 46,930 (188)

Oclacitinib for Controlling Pruritus and Associated Skin Lesions in 16 Horses With Allergic Dermatitis

open access: yesVeterinary Dermatology, EarlyView.
Background: Oclacitinib is a Janus kinase inhibitor approved for the treatment of pruritus associated with allergic dermatitis in dogs and may be effective in horses. Objectives: To evaluate the efficacy of oclacitinib in reducing pruritus and skin lesions in horses with allergic dermatitis.
Nuttawut Nuchprayoon   +6 more
wiley   +1 more source

Integrating Technology into Urticaria Management: Telemedicine, Remote Monitoring and Patient-Centered Care. [PDF]

open access: yesBiomedicines
Topa E   +9 more
europepmc   +1 more source

Clinical Findings, Treatment Recommendations, and Outcome in Dogs Following Ingestion of a Single Unintended Dose of Trilostane: 403 Cases (2008–2023)

open access: yesJournal of Veterinary Emergency and Critical Care, EarlyView.
ABSTRACT Objective To characterize the clinical signs and outcomes in dogs following ingestion of a single, unintended dose of trilostane. The secondary objective was to describe treatment recommendations given for this population. Design Retrospective evaluation of cases of canine trilostane exposure from February 2008 to August 2023. Setting Private,
Lindsey Summers   +2 more
wiley   +1 more source

Risk of injury associated with the sedative potential of second‐generation antihistamines: A nationwide retrospective cohort study

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 7, Page 2230-2238, July 2026.
Abstract Aim Individual second‐generation antihistamines may possess differential sedative potential due to the variability in central histamine receptor H1 occupancy. This study aimed to evaluate whether the sedative potential of second‐generation antihistamines is associated with the risk of injury during Japan's pollen season. Methods We conducted a
Jumpei Taniguchi   +3 more
wiley   +1 more source

Psychological Wellbeing of Patients with Chronic Spontaneous Urticaria and Its Relation to Their Overall Health-Related Quality of Life. [PDF]

open access: yesClin Cosmet Investig Dermatol
Saja MF   +6 more
europepmc   +1 more source

Hidden in Plain Sight: Systemic Mastocytosis Manifesting as Isolated Hepatosplenomegaly in the Absence of Cutaneous and Classical Manifestations—A Case Report and Literature Review

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Systemic mastocytosis (SM) is a rare clonal myeloproliferative neoplasm typically characterized by cutaneous lesions and mediator‐release symptoms. Presentations dominated by visceral organ involvement without skin findings are uncommon and pose a significant diagnostic challenge, often mimicking hematologic malignancies.
Muhammad Sadam Zeb   +9 more
wiley   +1 more source

Pityriasis Lichenoides: Comparison of Two Pediatric Patients and Its Relationships With Vaccines and Infections

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Pityriasis lichenoides (PL) is a benign, self‐limiting inflammatory condition, characterized by the appearance of papular, scaly, or necrotic lesions. Despite the rare incidence, clinicians should suspect its diagnosis in the presence of specific skin lesions and epidemiological contexts, as suggested by its association with infections and/or ...
Gregorio Serra   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy